ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CYNTHIA SUMNER MD

Internal Medicine

24,191

$2.5M

867
721 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$103
Average prescription price

Avg: $56

LARRY SMITH M.D.

Internal Medicine

24,139

$965K

596
354 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

CHRISTOPHER CROOKER M.D.

Internal Medicine

23,917

$1.52M

1344
1100 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $56

RAGHU LOLABHATTU MD

Internal Medicine

23,873

$1.11M

435
274 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

MOHAMMAD KHAN M.D

Internal Medicine

23,449

$1.33M

593
340 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

39%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $56

MARY WILES MD

Internal Medicine

23,385

$1.98M

870
654 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$85
Average prescription price

Avg: $56

JAMES LAMON MD

Internal Medicine

23,324

$1.63M

529
445 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 26%

$70
Average prescription price

Avg: $56

FRANK BIXLER M.D.

Internal Medicine

23,166

$1.1M

765
583 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

22%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

WENTZELLE KITCHENS M.D.

Internal Medicine

23,125

$1.06M

707
583 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

WARREN HENDERSON M.D.

Internal Medicine

23,122

$845K

738
601 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $56

POONAM SINGH MD

Internal Medicine

22,732

$1.57M

564
412 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $56

JIM WADE MD

Internal Medicine

22,463

$1.04M

602
526 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

GURURAJ NAYAK M.D.

Internal Medicine

22,312

$968K

499
305 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

49%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$43
Average prescription price

Avg: $56

RICHARD INGRAM MD

Internal Medicine

22,256

$1.26M

716
562 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $56

MARY BELL VAUGHN M.D.

Internal Medicine

22,218

$1.15M

723
589 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

ASHFAQ SAIYED M.D.

Internal Medicine

22,209

$910K

537
309 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

39%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$41
Average prescription price

Avg: $56

SAMUEL COBARRUBIAS M.D.

Internal Medicine

22,180

$1.1M

564
328 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

45%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

JACKIE STRINGFELLOW M.D.

Internal Medicine

22,068

$1.05M

732
616 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

DOUGLAS MOSS MD

Internal Medicine

21,898

$1.33M

511
351 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

38%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $56

VIJITHA PRASAD M.D.

Internal Medicine

21,753

$994K

663
516 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

ANDREW DEKLE MD

Internal Medicine

21,639

$891K

917
590 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$41
Average prescription price

Avg: $56

JILL BRYANT MD

Internal Medicine

21,514

$1.15M

891
756 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $56

BRIAN MOOGERFELD M.D.

Internal Medicine

21,384

$1.13M

542
402 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $56

MARSHALL TANNER M.D.

Internal Medicine

21,323

$1.31M

819
507 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

39%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $56

AJAY KUMAR M.D.

Internal Medicine

21,252

$1.06M

671
456 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank